Skip to main content
. Author manuscript; available in PMC: 2016 Jul 28.
Published in final edited form as: Lancet. 2010 Dec 13;376(9758):2086–2095. doi: 10.1016/S0140-6736(10)61508-5

Table 4. Impact of intervention on prevalence of ICD-10 CMD at 6 months, by baseline diagnostic group and facility type (secondary analyses).

Diagnostic group at baseline Type of facility
p-value for effect modification
All facilities PHC GPs
Screen positive cases (n=2429)
  Collaborative Stepped Care 354 (28.8%) 196 (27.7%) 158 (29.9%)
  Enhanced Usual Care 541 (38.6%) 375 (50.8%) 166 (29.4%)
  Risk difference (95% CI) -9.9% (-19.4%, -0.03%) -23.1% (-42.1%, -4.2%) -0.05% (-12.9%, 14.0%) <0.001
  Risk ratio (95% CI) 0.76 (0.57–1.02) 0.54 (0.37–0.81) 1.07 (0.66–1.74) 0.003
  P-value 0.06 0.01 0.76

Sub-threshold cases (n=468)
  Collaborative Stepped Care 30 (12.7%) 20 (12.4%) 10 (13.0%)
  Enhanced Usual Care 77 (25.0%) 49 (31.2%) 28 (19.9%)
  Risk difference (95% CI) -12.3% (-23.5%, -1.1%) -18.8% (-46.6%, 9.0%) -6.9% (-19.3%, 5.5%) 0.18
  Risk ratio (95% CI) 0.52 (0.29–0.96) 0.40 (0.11–1.38) 0.70 (0.31–1.59) 0.16
  P-value 0.04 0.11 0.35